Cerebral AL λ-amyloidoma: Clinical and pathomorphological characteristics. Review of the literature and of a patient

References

• Westermark P, Benson M D, Buxbaum J N, Cohen A S, Frangione B, Ikeda S, Masters C L, Merlini G, Saraiva M J, Sipe J D. Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid. J Protein Folding Disord 2005; 12: 1–4
   PubMed Web of Science ®Google Scholar
• Westermark P, Benson M D, Buxbaum J N, Cohen A S, Frangione B, Ikeda S, Masters C L, Merlini G, Saraiva M J, Sipe J D. Amyloid fibril protein nomenclature-2002. Amyloid. J Protein Folding Disord 2002; 9: 197–200
   PubMed Web of Science ®Google Scholar
• Buxbaum J N. The systemic amyloidoses. Curr Opin Rheumatol 2003; 16: 67–75
   Google Scholar
• Salytkow S. Zur Frage des lokalen Amyloids der Hirngefäße. Bemerkungen zu dem gleichnamigen Aufsatz von Morgenstern, Virchos Arch [A] 1935; 295: 590
   Google Scholar
• Harris J H, Rayport M. Primary ‘cerebral amyloidoma’. J Neuropath 1979; 38: 318
   Google Scholar
• Spaar F W, Goebel H H, Volles E, Wickboldt J. Tumor-like amyloid formation (amyloidoma) in the brain. J Neurol 1981; 224: 171–182
   PubMedGoogle Scholar
• Townsend J J, Tomiyasu U, MacKay A, Wilson C B. Central nervous system amyloid presenting as a mass lesion. J Neurosurg 1982; 56: 439–442
   PubMedGoogle Scholar
• Moreno A J, Brown J M, Brown T J, Graham G D, Yedinak M A. Scintigraphic findings in a primary cerebral amyloidoma. Clin Nucl Med 1983; 8: 528–530
   PubMedGoogle Scholar
• Hori A, Kitamoto T, Tateishi J, Hann P, Friede R L. Focal intracerebral accumulation of a novel type of amyloid protein. Acta Neuropathol 1988; 76: 212–215
   PubMedGoogle Scholar
• Linke R P, Gerhard L, Lottspeich F. Brain-restricted amyloidoma of immunoglobulin λ-light chain origin clinically resembling multiple sclerosis. Biol Chem Hoppe-Seyler 1992; 373: 1201–1209
   PubMedGoogle Scholar
• Cohen M, Lanska D, Roessmann U, Karaman B, Ganz E, Whitehouse P, Gambetti P. Amyloidoma of the CNS. I. Clinical and pathologic study. Neurology 1992; 42: 2019–2023
   PubMed Web of Science ®Google Scholar
• Eriksson L, Sletten K, Benson L, Westermark P. Tumor-like localized amyloid of the brain is derived from immunoglobulin light chain. Scand J Immunol 1993; 37: 623–626
   PubMed Web of Science ®Google Scholar
• Schroeder R, Linke R P, Voges J, Heindel W, Sturm V. Intracerebral Aλ amyloidoma diagnosed by stereotactic biopsy. Clin Neuropathol 1995; 14: 347–350
   PubMedGoogle Scholar
• Lee J, Krol G, Rosenblum M. Primary amyloidoma of the brain: CT and MR presentation. AJNR Am J Neuroradiol 1995; 16: 712–714
   PubMedGoogle Scholar
• Caerts B, Mol V, Sainte T, Wilms G, Van Den Bergh V, Stessens L. CT and MRI of amyloidoma of the CNS. Eur Radiol 1997; 7: 474–476
   PubMed Web of Science ®Google Scholar
• Laeng R H, Altermatt H J, Scheithauer B W, Zimmermann D R. Amyloidomas of the nervous system. Cancer 1998; 82: 362–374
   PubMed Web of Science ®Google Scholar
• Smadja P, Viaud B, Durand L, Bauchet L, Bossot P, Hane B, Campello C, Bonafe A. Amyloidoma of the central nervous system: CT and MR aspects. J Radiol 2000; 81: 975–978
   PubMedGoogle Scholar
• Blattler T, Siegel A M, Jochum W, Aguzzi A, Hess K. Primary cerebral amyloidoma. Neurology 2001; 56: 777
   PubMed Web of Science ®Google Scholar
• Vanhoenacker F, Van Paesschen R, Haumann R, Van Den Hauwe L, Parizel P M. Cerebral amyloidoma. JBR-BTR 2001; 84: 79
   PubMedGoogle Scholar
• Symko S C, Hattab E M, Steinberg G K, Lane B. Imaging of cerebral and brain stem amyloidomas. AJNR Am J Neuroradiol 2001; 22: 1353–1356
   PubMedGoogle Scholar
• Gallucci M, Caulo M, Splendiani A, Russo R, Ricci A, Galzio R. Neuroradiological findings in two cases of isolated amyloidoma of the central nervous system. Neuroradiology 2002; 44: 333–337
   PubMedGoogle Scholar
• Gandhi D, Wee R, Goyal M. CT and MR imaging of intracerebral amyloidoma: case report and review of the literature. AJNR Am J Neuroradiol 2003; 24: 519–522
   PubMedGoogle Scholar
• Tabatabai G, Baehring J, Hochberg F H. Primary amyloidoma of the brain parenchyma. Arch Neurol 2005; 62: 477–480
   PubMedGoogle Scholar
• Meir K, Maly B, Shoshan Y, Maly A, Soffer D. Cerebral amyloidoma diagnosed intraoperatively with squash preparations: a case report. Acta Cytol 2005; 49: 195–198
   PubMedGoogle Scholar
• Simoens W A, Van den Hauwe L, Van Hedent E, Warson F, Demaeseneer R, Williams D, De Schepper A MA. Amyloidoma of the skull base. AJNR Am J Neuroradiol 2000; 21: 1559–1562
   PubMed Web of Science ®Google Scholar
• Vorster S J, Lee J H, Ruggieri P. Amyloidoma of the Gasserian ganglion. AJNR Am J Neuroradiol 1998; 19: 1853–1855
   PubMed Web of Science ®Google Scholar
• McKechnie S, Yang F, Harper C G, McGee-Collett M, Henderson C JA, Liepnieks J J, Yazaki M, Benson M D, McLeod J G. Amyloidoma of a spinal root. Neurology 2003; 61: 834–836
   PubMed Web of Science ®Google Scholar
• Mulleman D, Flipo R M, Assaker R. Primary amyloidoma of the axis and acute spinal cord compression: a case report. Eur Spine J 2004; 13: 244–248
   PubMed Web of Science ®Google Scholar
• Consales A, Roncaroli F, Salvi F, Poppi M. Amyloidoma of the brachial plexus. Surg Neurol 2003; 59: 418–423
   PubMedGoogle Scholar
• Cakirer S, Karaarslan E, Arslan A. Spontaneously T1-hyperintense lesions of the brain on MRI: a pictorial review. Curr Probl Diagn Radiol 2003; 32: 194–217
   PubMedGoogle Scholar
• Warakaulle D R, Anslow P. Differential diagnosis od intracranial lesions with high signal on T1 or low signal on T2-weighted MRI. Clin Radiol 2003; 58: 922–933
   PubMedGoogle Scholar
• Sage M R, Wilson A J, Scroop R. Contrast media and the brain. The basis of CT and MR imaging enhancement. Neuroimaging Clin N Am 1998; 8: 695–707
   PubMed Web of Science ®Google Scholar
• Weckesser M, Schmidt D, Matheja P, Coenen H H, Langen K J. The role of L-3-I-123-iodine-α-methyl tyrosine-SPECT in cerebral gliomas. Nuklearmedizin 2000; 39: 233–240
   PubMedGoogle Scholar
• Turley H, Jones M, Erber W, Mayne K, de Waele M, Gatter K. VS38: a new monoclonal antibody for detecting plasma cell differentiation in routine sections. J Clin Pathol 1994; 47: 418–422
   PubMedGoogle Scholar
• Gertz M A, Comenzo R, Falk R H, Fermand J P, Hazenberg B P, Hawkins P N, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis. Am J Hematol 2005; 79: 319–328
   PubMed Web of Science ®Google Scholar
• Caille I, Allinquant B, Dupont E, Bouillot C, Langer A, Müller U, Prochiantz A. Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone. Development 2004; 131: 2173–2181
   PubMed Web of Science ®Google Scholar
• Nicoll J AR, Yamada M, Frackowiak J, Mazur-Kolecka B, Weller R O. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement. Neurobiol Aging 2004; 25: 589–597
   PubMed Web of Science ®Google Scholar
• Abbott N J. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int 2004; 45: 545–552
   PubMed Web of Science ®Google Scholar
• Mackie J B, Bading J, Ghiso J, Walker L, Wisniewski T, Frangione B, Zlokovic B V. Circulating amyloid-β peptide crosses the blood–brain barrier in aged monkeys and contributes to Alzheimer's disease lesions. Vasc Pharm 2002; 38: 303–313
   PubMedGoogle Scholar
• Sair H I, Doraiswarmy P M, Petrella J R. In vivo amyloid imaging in Alzheimer's disease. Neuroradiology 2004; 46: 93–104
   PubMedGoogle Scholar
• Hazenberg B PC, van Rijswijk M H, Piers D A, Lub-de Hooge M N, Vellenga E, Haagsma E B, Hawkins P N, Jager P LJ. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am J Med 2006; 119: 355.e15–355.e24
   Web of Science ®Google Scholar
• Krieger M D, Chandrasoma P T, Zee C S, Apuzzo M L. Role of stereotactic biopsy in the diagnosis and management of brain tumors. Semin Surg Oncol 1998; 14: 13–25
   PubMedGoogle Scholar
• Hazenberg B PC, van Gameren I I, Bijzet J, Jager P L, van Rijswijk M H. Diagnostic and therapeutic approach of systemic amyloidosis. Neth J Med 2004; 62: 121–128
   PubMed Web of Science ®Google Scholar
• van Gameren I I, Lokhorst H, Hazenberg B PC, Vellenga E. Therapeutic options in systemic AL amyloidosis. Neth J Med 2004; 62: 106–113
   PubMedGoogle Scholar
• Paccalin M, Hachulla E, Cazalet C, Tricot L, Carreiro M, Rubi M, Grateau G, Roblot P. Localized amyloidosis: a survey of 35 French cases. Amyloid 2005; 12: 239–245
   PubMed Web of Science ®Google Scholar
• Vidal R G, Ghiso J, Gallo G, Cohen M, Gambetti P L, Frangione B. Amyloidoma of the CNS: II. Immunohistochemical and biochemical study. Neurology 1992; 42: 2024–2028
   PubMed Web of Science ®Google Scholar